Recent advances in targeted therapies in acute myeloid leukemia.
Bhansali RS, Pratz KW, Lai C.
J Hematol Oncol. 2023 Mar 25;16(1):29. doi: 10.1186/s13045-023-01424-6.
Enhancing anti-tumour efficacy with immunotherapy combinations.
Meric-Bernstam F, Larkin J, Tabernero J, Bonini C.
Lancet. 2021 Mar 13;397(10278):1010-1022. doi: 10.1016/S0140-6736(20)32598-8. Epub 2020 Dec 4.
Immunotherapy for the treatment of multiple myeloma.
Boussi LS, Avigan ZM, Rosenblatt J.
Front Immunol. 2022 Oct 28;13:1027385. doi: 10.3389/fimmu.2022.1027385. eCollection 2022.
Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine.
Overchuk M, Weersink RA, Wilson BC, Zheng G.
ACS Nano. 2023 May 9;17(9):7979-8003. doi: 10.1021/acsnano.3c00891. Epub 2023 Apr 27.
Recent progress in nanomedicine for enhanced cancer chemotherapy.
Wei G, Wang Y, Yang G, Wang Y, Ju R.
Theranostics. 2021 Apr 19;11(13):6370-6392. doi: 10.7150/thno.57828. eCollection 2021.
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations.
Butterfield LH, Najjar YG.
Nat Rev Immunol. 2024 Jun;24(6):399-416. doi: 10.1038/s41577-023-00973-8. Epub 2023 Dec 6.
Combination Therapies for Obesity.
Camilleri M, Acosta A.
Metab Syndr Relat Disord. 2018 Oct;16(8):390-394. doi: 10.1089/met.2018.0075. Epub 2018 Jul 11.
Nanocarrier-based drug combination therapy for glioblastoma.
Zhao M, van Straten D, Broekman MLD, Préat V, Schiffelers RM.
Theranostics. 2020 Jan 1;10(3):1355-1372. doi: 10.7150/thno.38147. eCollection 2020.
Targeting AKT for cancer therapy.
Shariati M, Meric-Bernstam F.
Expert Opin Investig Drugs. 2019 Nov;28(11):977-988. doi: 10.1080/13543784.2019.1676726. Epub 2019 Oct 12.
[Effectiveness of different physical therapy in conservative treatment of plantar fasciitis: systematic review].
Díaz López AM, Guzmán Carrasco P.
Rev Esp Salud Publica. 2014 Jan-Feb;88(1):157-78. doi: 10.4321/S1135-57272014000100010.
